Inhibition of Stress-Inducible Kinase Pathways by Tumorigenic Mutant p53

More than 50% of human cancers contain p53 gene mutations and as a result accumulate altered forms of the full-length p53 protein. Although certain tumor types expressing mutant p53 protein have a poor prognostic process, the precise role of mutant p53 protein in highly malignant tumor cells is not...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Mol Cell Biol
Asıl Yazarlar:	Ohiro, Yoichi, Usheva, Anny, Kobayashi, Shinichiro, Duffy, Shannon L., Nantz, Regan, Gius, David, Horikoshi, Nobuo
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Taylor & Francis 2003
Konular:	Cell Growth and Development
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140653/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12482984/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/MCB.23.1.322-334.2003
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Inhibition of Stress-Inducible Kinase Pathways by Tumorigenic Mutant p53

Benzer Materyaller